Guardant Health Inc Market Cap ($12.69 Billion)
Market Cap & Net Worth: Guardant Health Inc (GH)
Guardant Health Inc market cap. Guardant Health Inc (NASDAQ:GH) has a market capitalization of $12.69 Billion ($12.69 Billion) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #1799 globally and #694 in its home market, demonstrating a 1.01% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guardant Health Inc's stock price $175.00 by its total outstanding shares 132599929 (132.60 Million). Also see cash efficiency ratio of Guardant Health Inc for how efficiently the company converts equity into cash flow.
Guardant Health Inc Market Cap History (2018–2026)
Guardant Health Inc market cap history from 2018 to 2026. Data shows growth from $4.98 Billion to $23.20 Billion (23.28% CAGR). Check Guardant Health Inc share price for real-time trading data and today's change.
Index Memberships
Guardant Health Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.49% | #33 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.03% | #210 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.83 Trillion | 0.69% | #24 of 263 |
Weight: Guardant Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Guardant Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guardant Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Guardant Health Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
13.79x
Guardant Health Inc's market cap is 13.79 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $4.98 Billion | $90.64 Million | -$85.06 Million | 54.99x | N/A |
| 2019 | $10.36 Billion | $214.38 Million | -$75.65 Million | 48.33x | N/A |
| 2020 | $17.09 Billion | $286.73 Million | -$253.78 Million | 59.60x | N/A |
| 2021 | $13.26 Billion | $373.65 Million | -$405.67 Million | 35.49x | N/A |
| 2022 | $3.61 Billion | $449.54 Million | -$654.59 Million | 8.02x | N/A |
| 2023 | $3.59 Billion | $563.95 Million | -$479.45 Million | 6.36x | N/A |
| 2024 | $4.05 Billion | $739.02 Million | -$436.37 Million | 5.48x | N/A |
| 2025 | $13.54 Billion | $982.02 Million | -$416.28 Million | 13.79x | N/A |
Competitor Companies of GH by Market Capitalization
Companies near Guardant Health Inc in the global market cap rankings as of November 4, 2026. Also see Guardant Health Inc (GH) total assets for a full breakdown of the balance sheet.
Key companies related to Guardant Health Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $162.54 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.02 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #546 globally with a market cap of $48.96 Billion USD ( CN¥334.59 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $698.34 |
| #142 | Danaher Corporation | NYSE:DHR | $162.54 Billion | $230.11 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.02 Billion | $388.63 |
| #546 | WuXi AppTec Co Ltd | SHG:603259 | $48.96 Billion | CN¥135.28 |
Market Capitalization of Guardant Health Inc (2018–2026)
Market capitalization of Guardant Health Inc from 2018 to today. Between 2018 and today, Guardant Health Inc's market cap moved from $4.98 Billion to $ 23.20 Billion, with a yearly change of 23.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $23.20 Billion | +71.33% |
| 2025 | $13.54 Billion | +234.34% |
| 2024 | $4.05 Billion | +12.94% |
| 2023 | $3.59 Billion | -0.55% |
| 2022 | $3.61 Billion | -72.81% |
| 2021 | $13.26 Billion | -22.39% |
| 2020 | $17.09 Billion | +64.93% |
| 2019 | $10.36 Billion | +107.87% |
| 2018 | $4.98 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Guardant Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.69 Billion USD |
| MoneyControl | $12.69 Billion USD |
| MarketWatch | $12.69 Billion USD |
| marketcap.company | $12.69 Billion USD |
| Reuters | $12.69 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tu… Read more